Phase 2 study of A797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin A/C-related dilated cardiomyopathyC. MacRae, M. R. G. Taylor,L. Mestroni, J. R. Moses,E. A. Ashley,M. T. Wheeler,N. K. Lakdawala, R. E. Hershberger,M. Ptaszynski,V. Sandor, M. E. Saunders,C. Oliver,P. A. Lee, D. P. JudgeEUROPEAN HEART JOURNAL（2016）引用 1|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
